These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pharmacological therapies for Angelman syndrome. Tan WH; Bird LM Wien Med Wochenschr; 2017 Jun; 167(9-10):205-218. PubMed ID: 26758979 [TBL] [Abstract][Full Text] [Related]
28. Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences. Grier MD; Carson RP; Lagrange AH Behav Brain Res; 2015 Sep; 291():260-267. PubMed ID: 26028516 [TBL] [Abstract][Full Text] [Related]
29. Angelman syndrome - insights into a rare neurogenetic disorder. Buiting K; Williams C; Horsthemke B Nat Rev Neurol; 2016 Oct; 12(10):584-93. PubMed ID: 27615419 [TBL] [Abstract][Full Text] [Related]
30. Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors. Tsagkaris C; Papakosta V; Miranda AV; Zacharopoulou L; Danilchenko V; Matiashova L; Dhar A Curr Gene Ther; 2020; 19(6):359-366. PubMed ID: 31914913 [TBL] [Abstract][Full Text] [Related]
31. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Mulherkar SA; Jana NR Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245 [TBL] [Abstract][Full Text] [Related]
32. Sex-dependent influence of postweaning environmental enrichment in Angelman syndrome model mice. Cosgrove JA; Kelly LK; Kiffmeyer EA; Kloth AD Brain Behav; 2022 Feb; 12(2):e2468. PubMed ID: 34985196 [TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic approaches for Angelman syndrome. Bi X; Sun J; Ji AX; Baudry M Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806 [TBL] [Abstract][Full Text] [Related]
34. Characterizing spine issues: If offers novel therapeutics to Angelman syndrome. Yang X Dev Neurobiol; 2020 May; 80(5-6):200-209. PubMed ID: 32378784 [TBL] [Abstract][Full Text] [Related]
35. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion. Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039 [TBL] [Abstract][Full Text] [Related]
36. Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome. Llewellyn KJ; Nalbandian A; Gomez A; Wei D; Walker N; Kimonis VE Neurobiol Dis; 2015 Apr; 76():77-86. PubMed ID: 25684537 [TBL] [Abstract][Full Text] [Related]
37. A Novel Chd8 Mutant Mouse Displays Altered Ultrasonic Vocalizations and Enhanced Motor Coordination. Hulbert SW; Wang X; Gbadegesin SO; Xu Q; Xu X; Jiang YH Autism Res; 2020 Oct; 13(10):1685-1697. PubMed ID: 32815320 [TBL] [Abstract][Full Text] [Related]
38. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072 [TBL] [Abstract][Full Text] [Related]
39. Analysis of peripheral amyloid precursor protein in Angelman Syndrome. Erickson CA; Wink LK; Baindu B; Ray B; Schaefer TL; Pedapati EV; Lahiri DK Am J Med Genet A; 2016 Sep; 170(9):2334-7. PubMed ID: 27327493 [TBL] [Abstract][Full Text] [Related]
40. The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Sutcliffe JS; Jiang YH; Galijaard RJ; Matsuura T; Fang P; Kubota T; Christian SL; Bressler J; Cattanach B; Ledbetter DH; Beaudet AL Genome Res; 1997 Apr; 7(4):368-77. PubMed ID: 9110176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]